Replicel Life Sciences Stock Probability of Future Stock Price Finishing Over 21.36
| RP Stock | CAD 0.01 0.00 0.00% |
RepliCel |
RepliCel Life Target Price Odds to finish over 21.36
The tendency of RepliCel Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over C$ 21.36 or more in 90 days |
| 0.01 | 90 days | 21.36 | close to zero percent |
Based on a normal probability distribution, the odds of RepliCel Life to move over C$ 21.36 or more in 90 days from now is close to zero percent (This RepliCel Life Sciences probability density function shows the probability of RepliCel Stock to fall within a particular range of prices over 90 days) . Probability of RepliCel Life Sciences price to stay between its current price of C$ 0.01 and C$ 21.36 at the end of the 90-day period is about 83.34 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.55 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, RepliCel Life will likely underperform. Additionally RepliCel Life Sciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. RepliCel Life Price Density |
| Price |
Predictive Modules for RepliCel Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as RepliCel Life Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.RepliCel Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. RepliCel Life is not an exception. The market had few large corrections towards the RepliCel Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold RepliCel Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of RepliCel Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.84 | |
β | Beta against Dow Jones | 1.55 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | -0.04 |
RepliCel Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of RepliCel Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for RepliCel Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| RepliCel Life generated a negative expected return over the last 90 days | |
| RepliCel Life has high historical volatility and very poor performance | |
| RepliCel Life has some characteristics of a very speculative penny stock | |
| RepliCel Life has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 353.74 K. Net Loss for the year was (311.73 K) with profit before overhead, payroll, taxes, and interest of 353.74 K. | |
| RepliCel Life Sciences currently holds about 1.16 M in cash with (1.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 59.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: RepliCel Life Sciences Urges Online Access for Shareholders - TipRanks |
RepliCel Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of RepliCel Stock often depends not only on the future outlook of the current and potential RepliCel Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. RepliCel Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 59.2 M | |
| Cash And Short Term Investments | 76.4 K |
RepliCel Life Technical Analysis
RepliCel Life's future price can be derived by breaking down and analyzing its technical indicators over time. RepliCel Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of RepliCel Life Sciences. In general, you should focus on analyzing RepliCel Stock price patterns and their correlations with different microeconomic environments and drivers.
RepliCel Life Predictive Forecast Models
RepliCel Life's time-series forecasting models is one of many RepliCel Life's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary RepliCel Life's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about RepliCel Life Sciences
Checking the ongoing alerts about RepliCel Life for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for RepliCel Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| RepliCel Life generated a negative expected return over the last 90 days | |
| RepliCel Life has high historical volatility and very poor performance | |
| RepliCel Life has some characteristics of a very speculative penny stock | |
| RepliCel Life has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 353.74 K. Net Loss for the year was (311.73 K) with profit before overhead, payroll, taxes, and interest of 353.74 K. | |
| RepliCel Life Sciences currently holds about 1.16 M in cash with (1.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 59.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: RepliCel Life Sciences Urges Online Access for Shareholders - TipRanks |
Additional Tools for RepliCel Stock Analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.